ImmunoCellular Therapeutics
Montvale, US · Delaware corporation
Founders & leadership
FD
Frank DouglasNamed on SEC filing
JK
Julie KampfNamed on SEC filing
RL
Robert LehmanNamed on SEC filing
EG
Eli GoldbergerNamed on SEC filing
WD
Wayne DansonNamed on SEC filing
IT
Irach TaraporewalaNamed on SEC filing
Reported raises · per SEC filings
Form D private placements$750K disclosed across 1 round · 2022
▶$750KraisedSep 2022 · 1 investors · PharmaceuticalsRule 506(b)
▶$750KraisedSep 2022 · 1 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Frank DouglasDirector
- Julie KampfDirector
- Robert LehmanDirector
- Eli GoldbergerExecutive Officer, Director
- Wayne DansonExecutive Officer
- Irach TaraporewalaExecutive Officer, Director
- Offering amount
- $5M
- Amount sold
- $750K
- Minimum investment
- $25K
- First sale
- Aug 2022
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has ImmunoCellular Therapeutics raised?
- ImmunoCellular Therapeutics has disclosed $750K raised across 1 round.
- Where is ImmunoCellular Therapeutics headquartered?
- ImmunoCellular Therapeutics is headquartered in Montvale, US.